US HEVA Rare Asset​/Indication Lead

Job title:

US HEVA Rare Asset / Indication Lead

* Location:

Morristown, NJ

About the Job

Sanofi is an R&D-driven, AI-powered biopharma company committed to improving people's lives and delivering compelling growth. We apply our deep understanding of the immune system to invent medicines and vaccines that treat and protect millions of people around the world, with an innovative pipeline that could benefit millions more. Our team is guided by one purpose: we chase the miracles of science to improve people's lives;

this inspires us to drive progress and deliver positive impact for our people and the communities we serve, by addressing the most urgent healthcare, environmental, and societal challenges of our time.

Sanofi is committed to advancing breakthroughs in cancer care and rare diseases, expanding scientific understanding and improving outcomes for patients facing these serious, often life-threatening conditions.

Through a focused and growing portfolio of innovative therapies, Sanofi aims to address critical gaps in care and deliver meaningful, potentially transformative treatment options for underserved patient communities.

We are one bold HEOR team leveraging innovative HEOR to transform patient care and access. As HEOR experts, we lead the generation and dissemination of robust, business-relevant evidence to demonstrate value and drive access to medicines. The HEVA organization is driven by five core values that define how we work and deliver impact. We operate as One Team, partnering without boundaries while pursuing a Bold Purpose through ambitious, measurable goals.

Grounded in Scientific Excellence with Relevance and deep technical expertise, we embrace Innovation in Action to transform how we research and deliver Impact for People, creating meaningful outcomes for patients, the healthcare ecosystem, and our colleagues who make it all possible.

This role is accountable for leading US HEOR strategy and execution for the Rare Hemophilia portfolio - including ALTUVIIIO, QFITLIA, Eloctat & Alprolix, and Cablivi (aTTP) - serving as the primary US HEVA point of contact for the portfolio and partnering cross-functionally to drive the generation, translation, and dissemination of high-quality, decision-relevant evidence to support access in the United States

About Sanofi

We're an R&D-driven, AI-powered biopharma company committed to improving people's lives and delivering compelling growth. Our deep understanding of the immune system - and innovative pipeline - enables us to invent medicines and vaccines that treat and protect millions of people around the world. Together, we chase the miracles of science to improve people's lives.

Main responsibilities:

Strategic Business Impact

* Develop and implement US payer-specific HEVA strategy in close collaboration with cross-functional team members to lead/implement VEST team structure for rare hemophilia portfolio.

* Drive measurable business impact through execution of HEVA tactics that directly support commercial objectives and market access goals compliantly and efficiently.

* Execute comprehensive US HEVA tactics for the Rare Hemophilia portfolio, contributing to strategic planning and ensuring alignment with broader portfolio objectives

* Partner with commercial teams to translate HEVA insights into actionable business strategies

* Partner with access and medical team members to generate and disseminate actionable high-impact evidence

* Develop business-relevant US research agendas through cross-functional input and alignment, ensuring evidence priorities are reflected in broader Sanofi planning documents

Internal Partnerships and Senior Management Engagement

* Build and maintain strong relationships with cross-functional teams to ensure pricing and access decisions are aligned with the demonstrable value of the Rare Hemophilia portfolio

* Align closely with the Global HEVA team to ensure US insights inform global strategies and coordinate evidence generation, modeling, and evidence synthesis activities

* Communicate complex health economics concepts and strategic recommendations to cross-functional stakeholders with clarity and impact

* Influence key business decisions through data-driven insights and strategic HEVA recommendations

* Ensure clinical development plans for Rare Hemophilia indications are designed to deliver true differentiation aligned to Sanofi's best-in-class or first-in-class ambition

Health Economics Research and Evidence Generation

* Health Economics Research and Evidence Generation

Oversee the design, execution, and publication of high-quality health economics and outcomes research studies - including economic modeling, database analysis, observational research, systematic literature review, evidence synthesis, and AMCP dossier development - for the Rare Hemophilia portfolio

* Contribute to the development of comprehensive real-world evidence strategies that support product lifecycle management

* Ensure scientific rigor and regulatory compliance across all HEVA…